Baolingbao Biology Co Ltd (002286) — Working Capital to Net Assets Ratio
Baolingbao Biology Co Ltd (002286) has a Working Capital to Net Assets ratio of 18.0% as of September 2025. Working capital of CN¥397.36 Million (current assets of CN¥878.69 Million minus current liabilities of CN¥481.32 Million) is measured against net assets of CN¥2.20 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 002286 net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Baolingbao Biology Co Ltd Working Capital to Net Assets (2006–2024)
This chart shows how Baolingbao Biology Co Ltd's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2006 to 2024. As of September 2025, the ratio stands at 18.0%, reflecting working capital of CN¥397.36 Million against net assets of CN¥2.20 Billion CNY. Check 002286 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Baolingbao Biology Co Ltd (2006–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Baolingbao Biology Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Baolingbao Biology Co Ltd worth.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 11.5% | CN¥234.12 Million | CN¥2.04 Billion | CN¥810.22 Million | CN¥576.10 Million | ▲ +0.9 pp |
| 2023 | 10.6% | CN¥209.39 Million | CN¥1.98 Billion | CN¥785.87 Million | CN¥576.47 Million | ▼ -1.2 pp |
| 2022 | 11.8% | CN¥236.32 Million | CN¥2.00 Billion | CN¥995.78 Million | CN¥759.46 Million | ▲ +1.0 pp |
| 2021 | 10.8% | CN¥195.05 Million | CN¥1.81 Billion | CN¥1.31 Billion | CN¥1.12 Billion | ▲ +7.5 pp |
| 2020 | 3.2% | CN¥51.75 Million | CN¥1.60 Billion | CN¥1.01 Billion | CN¥956.41 Million | ▲ +0.2 pp |
| 2019 | 3.0% | CN¥46.84 Million | CN¥1.57 Billion | CN¥945.57 Million | CN¥898.73 Million | ▲ +6.7 pp |
| 2018 | -3.8% | CN¥-57.97 Million | CN¥1.54 Billion | CN¥926.55 Million | CN¥984.52 Million | ▼ -17.4 pp |
| 2017 | 13.6% | CN¥207.98 Million | CN¥1.53 Billion | CN¥756.91 Million | CN¥548.93 Million | ▼ -1.9 pp |
| 2016 | 15.6% | CN¥235.05 Million | CN¥1.51 Billion | CN¥622.87 Million | CN¥387.82 Million | ▲ +0.6 pp |
| 2015 | 15.0% | CN¥222.23 Million | CN¥1.48 Billion | CN¥624.97 Million | CN¥402.74 Million | ▼ -11.0 pp |
| 2014 | 26.0% | CN¥376.97 Million | CN¥1.45 Billion | CN¥657.46 Million | CN¥280.48 Million | ▼ -15.2 pp |
| 2013 | 41.2% | CN¥591.58 Million | CN¥1.44 Billion | CN¥797.86 Million | CN¥206.27 Million | ▲ +28.3 pp |
| 2012 | 12.9% | CN¥105.73 Million | CN¥817.45 Million | CN¥373.89 Million | CN¥268.15 Million | ▲ +5.5 pp |
| 2011 | 7.4% | CN¥56.50 Million | CN¥760.53 Million | CN¥389.31 Million | CN¥332.80 Million | ▼ -8.6 pp |
| 2010 | 16.0% | CN¥112.57 Million | CN¥703.11 Million | CN¥403.93 Million | CN¥291.36 Million | ▼ -10.8 pp |
| 2009 | 26.8% | CN¥177.45 Million | CN¥662.61 Million | CN¥538.40 Million | CN¥360.95 Million | ▲ +36.9 pp |
| 2008 | -10.2% | CN¥-24.21 Million | CN¥238.05 Million | CN¥258.16 Million | CN¥282.36 Million | ▲ +25.7 pp |
| 2007 | -35.9% | CN¥-69.36 Million | CN¥193.28 Million | CN¥167.57 Million | CN¥236.93 Million | ▲ +66.6 pp |
| 2006 | -102.5% | CN¥-115.37 Million | CN¥112.53 Million | CN¥254.94 Million | CN¥370.31 Million | — |